{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:05:35Z","timestamp":1790417135415,"version":"4.1.0"},"reference-count":164,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T00:00:00Z","timestamp":1534982400000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["201567\/Z\/16\/Z"],"award-info":[{"award-number":["201567\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000765","name":"UCL","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000691","name":"Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","award":["203147\/Z\/16\/Z"],"award-info":[{"award-number":["203147\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/brain\/awy211","type":"journal-article","created":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T11:32:14Z","timestamp":1531567934000},"source":"Crossref","is-referenced-by-count":21,"title":["Can neuroimaging predict dementia in Parkinson\u2019s disease?"],"prefix":"10.1093","author":[{"given":"Juliette H","family":"Lanskey","sequence":"first","affiliation":[{"name":"Institute of Neurology, UCL, Queen Square, London, UK"},{"name":"Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"McColgan","sequence":"additional","affiliation":[{"name":"Huntington\u2019s Disease Centre, UCL, Queen Square, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette E","family":"Schrag","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, Royal Free Campus UCL Institute of Neurology, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Acosta-Cabronero","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Human Neuroimaging, UCL, Queen Square, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraint","family":"Rees","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Human Neuroimaging, UCL, Queen Square, London, UK"},{"name":"Institute of Cognitive Neuroscience, UCL, Queen Square, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huw R","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, Royal Free Campus UCL Institute of Neurology, UK"},{"name":"Department of Movement Disorders, UCL, Queen Square, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimona S","family":"Weil","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Human Neuroimaging, UCL, Queen Square, London, UK"},{"name":"UCL Dementia Research Centre, Queen Square, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,8,22]]},"reference":[{"key":"key\n\t\t\t\t20180823051321_awy211-B1","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1212\/01.wnl.0000338632.00552.cb","article-title":"Cognitive impairment in incident, untreated parkinson disease: the norwegian parkwest study","volume":"72","author":"Aarsland","year":"2009","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180823051321_awy211-B2","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1212\/WNL.0b013e3181f39d0e","article-title":"Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis","volume":"75","author":"Aarsland","year":"2010","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180823051321_awy211-B3","doi-asserted-by":"crossref","first-page":"45347","DOI":"10.1038\/srep45347","article-title":"Discriminating cognitive status in Parkinson\u2019s disease through functional connectomics and machine learning","volume":"7","author":"Ab\u00f3s","year":"2017","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t20180823051321_awy211-B4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/brain\/aww278","article-title":"The whole-brain pattern of magnetic susceptibility perturbations in Parkinson\u2019s disease","volume":"140","author":"Acosta-Cabronero","year":"2016","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180823051321_awy211-B5","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/hbm.22302","article-title":"Mild cognitive impairment in Parkinson\u2019s disease is associated with a distributed pattern of brain white matter damage","volume":"35","author":"Agosta","year":"2014","journal-title":"Hum Brain Mapp"},{"key":"key\n\t\t\t\t20180823051321_awy211-B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0177924","article-title":"Regional brain amyloid-\u03b2 accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia","volume":"12","author":"Akhtar","year":"2017","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180823051321_awy211-B7","doi-asserted-by":"crossref","first-page":"1127.e11","DOI":"10.1016\/j.neurobiolaging.2011.11.028","article-title":"What predicts cognitive decline in de novo Parkinson\u2019s disease?","volume":"33","author":"Arnaldi","year":"2012","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t20180823051321_awy211-B8","first-page":"1","article-title":"Exenatide once weekly versus placebo in Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled trial","volume":"6736","author":"Athauda","year":"2017","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180823051321_awy211-B9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.parkreldis.2009.01.003","article-title":"Hippocampal atrophy predicts conversion to dementia after STN-DBS in Parkinson\u2019s disease","volume":"15","author":"Aybek","year":"2009","journal-title":"Park Relat Disord"},{"key":"key\n\t\t\t\t20180823051321_awy211-B10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jns.2016.11.068","article-title":"Longitudinal study of cognitive and cerebral metabolic changes in Parkinson\u2019s disease","volume":"372","author":"Baba","year":"2017","journal-title":"J Neurol Sci"},{"key":"key\n\t\t\t\t20180823051321_awy211-B11","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1002\/hbm.22499","article-title":"Functional brain networks and cognitive deficits in Parkinson\u2019s disease","volume":"35","author":"Baggio","year":"2014","journal-title":"Hum Brain Mapp"},{"key":"key\n\t\t\t\t20180823051321_awy211-B12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/hbm.22622","article-title":"Cognitive impairment and resting-state network connectivity in Parkinson\u2019s disease","volume":"36","author":"Baggio","year":"2015","journal-title":"Hum Brain Mapp"},{"key":"key\n\t\t\t\t20180823051321_awy211-B13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neurobiolaging.2008.12.009","article-title":"Functional brain changes in early Parkinson\u2019s disease during motor response and motor inhibition","volume":"32","author":"Baglio","year":"2011","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t20180823051321_awy211-B14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jamaneurol.2014.2757","article-title":"Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects","volume":"72","author":"Bohnen","year":"2015","journal-title":"JAMA Neurol"},{"key":"key\n\t\t\t\t20180823051321_awy211-B15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00415-005-0971-0","article-title":"Cognitive correlates of cortical cholinergic denervation in Parkinson\u2019s disease and parkinsonian dementia","volume":"253","author":"Bohnen","year":"2006","journal-title":"J Neurol"},{"key":"key\n\t\t\t\t20180823051321_awy211-B16","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2967\/jnumed.111.089946","article-title":"Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study","volume":"52","author":"Bohnen","year":"2011","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t20180823051321_awy211-B17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3940(01)02124-3","article-title":"Positron emission tomography shows that impaired frontal lobe functioning in Parkinson\u2019s disease is related to dopaminergic hypofunction in the caudate nucleus","volume":"311","author":"Br\u00fcck","year":"2001","journal-title":"Neurosci Lett"},{"key":"key\n\t\t\t\t20180823051321_awy211-B18","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3233\/JAD-160698","article-title":"Cross-sectional and longitudinal cognitive correlates of FDDNP PET and CSF amyloid-\u03b2 and Tau in Parkinson\u2019s disease","volume":"55","author":"Buongiorno","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"key\n\t\t\t\t20180823051321_awy211-B19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.expneurol.2012.01.011","article-title":"Axon degeneration in Parkinson\u2019 s disease","volume":"246","author":"Burke","year":"2013","journal-title":"Exp Neurol"},{"key":"key\n\t\t\t\t20180823051321_awy211-B20","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1212\/WNL.0b013e31829e6f94","article-title":"Principal component analysis of PiB distribution in Parkinson and Alzheimer diseases","volume":"81","author":"Campbell","year":"2013","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180823051321_awy211-B21","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1212\/WNL.0b013e318259e1c5","article-title":"Hippocampal abnormalities and memory deficits in Parkinson disease: a multimodal imaging study","volume":"78","author":"Carlesimo","year":"2012","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180823051321_awy211-B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0175674","article-title":"Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease","volume":"12","author":"Caspell-Garcia","year":"2017","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180823051321_awy211-B23","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.neurobiolaging.2010.11.015","article-title":"Volumetric analysis of the substantia innominata in patients with Parkinson\u2019s disease according to cognitive status","volume":"33","author":"Choi","year":"2012","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t20180823051321_awy211-B24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/brain\/awt337","article-title":"Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson\u2019s disease with mild cognitive impairment","volume":"137","author":"Christopher","year":"2014","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180823051321_awy211-B25","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1523\/JNEUROSCI.5427-08.2009","article-title":"Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a Rat Model of AAV \u03b1-synucleinopathy","volume":"29","author":"Chung","year":"2009","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20180823051321_awy211-B26","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awr031","article-title":"Lewy- and Alzheimer-type pathologies in Parkinson\u2019s disease dementia: which is more important?","volume":"134","author":"Compta","year":"2011","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180823051321_awy211-B27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.parkreldis.2013.03.009","article-title":"Combined dementia-risk biomarkers in Parkinson\u2019s disease: a prospective longitudinal study","volume":"19","author":"Compta","year":"2013","journal-title":"Park Relat Disord"},{"key":"key\n\t\t\t\t20180823051321_awy211-B28","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00259-015-3231-2","article-title":"Tau imaging in neurodegenerative diseases","volume":"43","author":"Dani","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"key\n\t\t\t\t20180823051321_awy211-B29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/1533317512470207","article-title":"Diffusion tensor imaging reveals white matter changes associated with cognitive status in patients with Parkinson\u2019s disease","volume":"28","author":"Deng","year":"2013","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"key\n\t\t\t\t20180823051321_awy211-B30","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/01.mnm.0000243370.18883.62","article-title":"Regional cerebral blood flow in Parkinson\u2019s disease as an indicator of cognitive impairment","volume":"27","author":"Derejko","year":"2006","journal-title":"Nucl Med Commun"},{"key":"key\n\t\t\t\t20180823051321_awy211-B31","first-page":"461","article-title":"The role of oxidative stress in Parkinson\u2019s disease","volume":"3","author":"Dias","year":"2014","journal-title":"J Park. Dis"},{"key":"key\n\t\t\t\t20180823051321_awy211-B32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/ane.12375","article-title":"Cognitive function in the early phase of Parkinson\u2019s disease, a five-year follow-up","volume":"132","author":"Domell\u00f6f","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"key\n\t\t\t\t20180823051321_awy211-B200","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/mds.26417","article-title":"Quantitative susceptibility mapping of the midbrain in Parkinson\u2019s disease","volume":"31","author":"Du","year":"2016","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20180823051321_awy211-B33","first-page":"317","article-title":"HHS Public Access","volume":"31","author":"Du","year":"2017"},{"key":"key\n\t\t\t\t20180823051321_awy211-B34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/mds.26312","article-title":"Gray and white matter imaging: a biomarker for cognitive impairment in early Parkinson\u2019s disease?","volume":"31","author":"Duncan","year":"2015","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20180823051321_awy211-B35","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/npp.2012.255","article-title":"Microglia, amyloid, and glucose metabolism in Parkinson\u2019s disease with and without dementia","volume":"38","author":"Edison","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t20180823051321_awy211-B36","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1474-4422(12)70138-2","article-title":"Functional brain activity and presynaptic dopamine uptake in patients with Parkinson\u2019s disease and mild cognitive impairment: a cross-sectional study","volume":"11","author":"Ekman","year":"2012","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20180823051321_awy211-B37","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20180823051321_awy211-B38","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/brain\/awx118","article-title":"Clinical criteria for subtyping Parkinson\u2019s disease: biomarkers and longitudinal progression","volume":"140","author":"Fereshtehnejad","year":"2017","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180823051321_awy211-B39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp-2016-313918","article-title":"Cerebral glucose metabolism and cognition in newly diagnosed Parkinson\u2019s disease: ICICLE-PD study","volume":"88","author":"Firbank","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20180823051321_awy211-B40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/ene.13205","article-title":"Progression of subcortical atrophy in mild Parkinson\u2019s disease and its impact on cognition","volume":"24","author":"Foo","year":"2017","journal-title":"Eur J Neurol"},{"key":"key\n\t\t\t\t20180823051321_awy211-B41","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.euroneuro.2014.02.011","article-title":"Connectomics: a new paradigm for understanding brain disease","volume":"25","author":"Fornito","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"key\n\t\t\t\t20180823051321_awy211-B42","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1002\/mds.23393","article-title":"Amyloid imaging of Lewy body-associated disorders","volume":"25","author":"Foster","year":"2010","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20180823051321_awy211-B43","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(04)15441-X","article-title":"Imaging cerebral atrophy: normal ageing to Alzheimer\u2019s disease","volume":"363","author":"Fox","year":"2004","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180823051321_awy211-B44","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1148\/radiol.2016160274","article-title":"Structural brain connectome and cognitive impairment in Parkinson disease","volume":"283","author":"Galantucci","year":"2017","journal-title":"Radiology"},{"key":"key\n\t\t\t\t20180823051321_awy211-B45","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neulet.2017.08.028","article-title":"Changes of brain structure in Parkinson\u2019s disease patients with mild cognitive impairment analyzed via VBM technology","volume":"658","author":"Gao","year":"2017","journal-title":"Neurosci Lett"},{"key":"key\n\t\t\t\t20180823051321_awy211-B46","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s00259-012-2198-5","article-title":"Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson\u2019s disease","volume":"39","author":"Garcia-Garcia","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"key\n\t\t\t\t20180823051321_awy211-B47","article-title":"Parkinson\u2019s disease with mild cognitive impairment: severe cortical thinning antedates dementia","author":"Gasca-Salas","year":"2017","journal-title":"Brain Imaging Behav"},{"key":"key\n\t\t\t\t20180823051321_awy211-B48","doi-asserted-by":"crossref","first-page":"465","DOI":"10.55782\/ane-2014-2009","article-title":"The neural correlates of specific executive dysfunctions in Parkinson\u2019s disease","volume":"74","author":"Gawrys","year":"2014","journal-title":"Acta Neurobiol Exp"},{"key":"key\n\t\t\t\t20180823051321_awy211-B49","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jns.2016.12.030","article-title":"Regional volumetric change in Parkinson\u2019s disease with cognitive decline","volume":"373","author":"Gee","year":"2017","journal-title":"J Neurol Sci"},{"key":"key\n\t\t\t\t20180823051321_awy211-B50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neuropsychologia.2014.12.022","article-title":"Compensatory fronto-parietal hyperactivation during set-shifting in unmedicated patients with Parkinson\u2019s disease","volume":"68","author":"Gerrits","year":"2015","journal-title":"Neuropsychologia"},{"key":"key\n\t\t\t\t20180823051321_awy211-B51","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1212\/WNL.0b013e31827b1a07","article-title":"Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia","volume":"80","author":"Gomperts","year":"2013","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180823051321_awy211-B52","first-page":"1","article-title":"Tau positron emission tomographic imaging in lewy body diseases","volume":"2129","author":"Gomperts","year":"2016","journal-title":"JAMA Neurol"},{"key":"key\n\t\t\t\t20180823051321_awy211-B53","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/mds.25048","article-title":"Brain amyloid and cognition in Lewy body diseases","volume":"27","author":"Gomperts","year":"2012","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20180823051321_awy211-B54","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1093\/brain\/awu159","article-title":"Grey matter hypometabolism and atrophy in Parkinson\u2019s disease with cognitive impairment: a two-step process","volume":"137","author":"Gonz\u00e1lez-Redondo","year":"2014","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180823051321_awy211-B55","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00213-010-2089-z","article-title":"Functional topography of midbrain and pontine serotonergic systems: implications for synaptic regulation of serotonergic circuits","volume":"213","author":"Hale","year":"2011","journal-title":"Psychopharmacology"},{"key":"key\n\t\t\t\t20180823051321_awy211-B56","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/brain\/awu036","article-title":"Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson\u2019s disease longitudinally","volume":"137","author":"Hanganu","year":"2014","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180823051321_awy211-B57","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/RLU.0b013e3182873511","article-title":"Brain regions associated with cognitive impairment in patients with Parkinson disease","volume":"38","author":"Hattori","year":"2013","journal-title":"Clin Nucl Med"},{"key":"key\n\t\t\t\t20180823051321_awy211-B58","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hbm.21245","article-title":"Cognitive status correlates with white matter alteration in Parkinson\u2019s disease","volume":"33","author":"Hattori","year":"2012","journal-title":"Hum Brain Mapp"},{"key":"key\n\t\t\t\t20180823051321_awy211-B59","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/nn.4171","article-title":"Canonical genetic signatures of the adult human brain","volume":"18","author":"Hawrylycz","year":"2015","journal-title":"Nat Neurosci"},{"key":"key\n\t\t\t\t20180823051321_awy211-B60","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nature11405","article-title":"An anatomically comprehensive atlas of the adult human brain transcriptome","volume":"489","author":"Hawrylycz","year":"2012","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180823051321_awy211-B61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fgene.2017.00177","article-title":"Mitochondria: a common target for genetic mutations and environmental toxicants in Parkinson\u2019s disease","volume":"8","author":"Helley","year":"2017","journal-title":"Front Genet"},{"key":"key\n\t\t\t\t20180823051321_awy211-B62","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1212\/01.wnl.0000191154.78131.f6","article-title":"Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways","volume":"65","author":"Hilker","year":"2005","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180823051321_awy211-B63","doi-asserted-by":"crossref","first-page":"46","DOI":"10.17116\/jnevro20171175146-51","article-title":"Characteristics of cerebral glucose metabolism in patients with cognitive impairment in Parkinson\u2019s disease [in Russian]","volume":"117","author":"Homenko","year":"2017","journal-title":"\u017durnal Nevrol Psihiatr Im S S Korsakova"},{"issue":"Pt 2","key":"key\n\t\t\t\t20180823051321_awy211-B64","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/brain\/123.2.340","article-title":"Cortical dysfunction in non-demented Parkinson\u2019s disease patients: a combined (31)P-MRS and (18)FDG-PET study","volume":"123","author":"Hu","year":"2000","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180823051321_awy211-B65","first-page":"24","article-title":"Mild cognitive impairment in patients with Parkinson\u2019s disease: a voxel-based morphometry analysis of gray matter.","volume":"29","author":"Hu","year":"2013"},{"key":"key\n\t\t\t\t20180823051321_awy211-B66","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.neuroimage.2006.09.003","article-title":"Metabolic brain networks associated with cognitive function in Parkinson\u2019s disease","volume":"34","author":"Huang","year":"2007","journal-title":"Neuroimage"},{"key":"key\n\t\t\t\t20180823051321_awy211-B67","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.parkreldis.2012.07.002","article-title":"In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson\u2019s disease","volume":"19","author":"Iannaccone","year":"2013","journal-title":"Park Relat Disord"},{"key":"key\n\t\t\t\t20180823051321_awy211-B68","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","article-title":"Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains","volume":"106","author":"Imamura","year":"2003","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180823051321_awy211-B69","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S1474-4422(16)30291-5","article-title":"Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis","volume":"16","author":"Irwin","year":"2017","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20180823051321_awy211-B70","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson\u2019s disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"key\n\t\t\t\t20180823051321_awy211-B71","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.parkreldis.2010.08.021","article-title":"[11C]PIB-, [18F]FDG-PET and MRI imaging in patients with Parkinson\u2019s disease with and without dementia","volume":"16","author":"Jokinen","year":"2010","journal-title":"Park Relat Disord"},{"key":"key\n\t\t\t\t20180823051321_awy211-B72","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1007\/s00330-013-2775-4","article-title":"Relationship between cognitive impairment and white-matter alteration in Parkinson\u2019s disease with dementia: tract-based spatial statistics and tract-specific analysis","volume":"23","author":"Kamagata","year":"2013","journal-title":"Eur Radiol"},{"key":"key\n\t\t\t\t20180823051321_awy211-B73","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1002\/hbm.23628","article-title":"Gray matter abnormalities in idiopathic Parkinson\u2019s disease: evaluation by diffusional kurtosis imaging and neurite orientation dispersion and density imaging","volume":"3722","author":"Kamagata","year":"2017","journal-title":"Hum Brain Mapp"},{"key":"key\n\t\t\t\t20180823051321_awy211-B74","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.parkreldis.2014.08.024","article-title":"Hippocampal volume and white matter disease in the prediction of dementia in Parkinson\u2019s disease","volume":"20","author":"Kandiah","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"key\n\t\t\t\t20180823051321_awy211-B75","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cortex.2016.04.021","article-title":"Default mode network differences between rigidity- and tremor-predominant Parkinson\u2019s disease","volume":"81","author":"Karunanayaka","year":"2016","journal-title":"Cortex"},{"key":"key\n\t\t\t\t20180823051321_awy211-B76","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/089198879100400404","article-title":"Cerebral blood flow and dementia in Parkinson\u2019s disease","volume":"4","author":"Kawabata","year":"1991","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"key\n\t\t\t\t20180823051321_awy211-B77","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000341998","article-title":"Cognitive impairment in Parkinson\u2019s disease: the dual syndrome hypothesis","volume":"11","author":"Kehagia","year":"2012","journal-title":"Neurodegener Dis"},{"key":"key\n\t\t\t\t20180823051321_awy211-B78","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1212\/WNL.0b013e3181d55f61","article-title":"Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo","volume":"74","author":"Klein","year":"2010","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180823051321_awy211-B79","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/hbm.22006","article-title":"Prefrontal dopaminergic receptor abnormalities and executive functions in Parkinson\u2019s disease","volume":"34","author":"Ko","year":"2013","journal-title":"Hum Brain Mapp"},{"key":"key\n\t\t\t\t20180823051321_awy211-B201","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fnagi.2016.00259","article-title":"Disrupted nodal and hub organization account for brain network abnormalities in Parkinson's disease","volume":"8","author":"Koshimori","year":"2016","journal-title":"Front Aging Neurosci"},{"key":"key\n\t\t\t\t20180823051321_awy211-B80","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00702-011-0723-5","article-title":"The default mode network integrity in patients with Parkinson\u2019s disease is levodopa equivalent dose-dependent","volume":"119","author":"Krajcovicova","year":"2012","journal-title":"J Neural Transm"},{"key":"key\n\t\t\t\t20180823051321_awy211-B81","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ana.410400309","article-title":"In vivo mapping of cholinergic terminals in normal aging, Alzheimer\u2019s disease, and Parkinson\u2019s disease","volume":"40","author":"Kuhl","year":"1996","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20180823051321_awy211-B82","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3233\/JPD-160881","article-title":"Is axonal degeneration a key early event in Parkinson\u2019s disease?","volume":"6","author":"Kurowska","year":"2016","journal-title":"J Parkinsons Dis"},{"key":"key\n\t\t\t\t20180823051321_awy211-B83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0162460","article-title":"Quantitative susceptibility mapping in Parkinson\u2019s disease","volume":"11","author":"Langkammer","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180823051321_awy211-B84","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/jmri.1076","article-title":"Diffusion tensor imaging: concepts and applications","volume":"13","author":"Le Bihan","year":"2001","journal-title":"J Magn Reson Imaging"},{"key":"key\n\t\t\t\t20180823051321_awy211-B85","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fnsys.2014.00045","article-title":"Large-scale resting state network correlates of cognitive impairment in Parkinson\u2019s disease and related dopaminergic deficits","volume":"8","author":"Lebedev","year":"2014","journal-title":"Front Syst Neurosci"},{"key":"key\n\t\t\t\t20180823051321_awy211-B86","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.1523\/JNEUROSCI.23-15-06351.2003","article-title":"Cognitive impairments in early Parkinson\u2019s disease are accompanied by reductions in activity in frontostriatal neural circuitry","volume":"23","author":"Lewis","year":"2003","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20180823051321_awy211-B87","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12640-010-9187-x","article-title":"Oxidative stress partially contributes to iron-induced alpha-synuclein aggregation in SK-N-SH cells","volume":"19","author":"Li","year":"2011","journal-title":"Neurotox Res"},{"key":"key\n\t\t\t\t20180823051321_awy211-B88","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society Task Force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20180823051321_awy211-B89","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1474-4422(17)30122-9","article-title":"Prediction of cognition in Parkinson\u2019s disease with a clinical\u2013genetic score: a longitudinal analysis of nine cohorts","volume":"16","author":"Liu","year":"2017","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20180823051321_awy211-B90","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/hbm.23474","article-title":"Cognitive phenotypes in parkinson\u2019s disease differ in terms of brain-network organization and connectivity","volume":"38","author":"Lopes","year":"2017","journal-title":"Hum Brain Mapp"},{"key":"key\n\t\t\t\t20180823051321_awy211-B91","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/ane.12259","article-title":"Nicotinic alpha4beta2 acetylcholine receptors and cognitive function in Parkinson\u2019s disease","volume":"130","author":"Lorenz","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"key\n\t\t\t\t20180823051321_awy211-B92","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00415-015-7750-3","article-title":"Functional connectome assessed using graph theory in drug-naive Parkinson\u2019s disease","volume":"262","author":"Luo","year":"2015","journal-title":"J Neurol"},{"key":"key\n\t\t\t\t20180823051321_awy211-B93","first-page":"2623","article-title":"Cerebral glucose metabolism in Parkinson\u2019s disease with dementia [in Chinese]","volume":"88","author":"Ma","year":"2008","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"key\n\t\t\t\t20180823051321_awy211-B94","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1093\/brain\/awv211","article-title":"Baseline and longitudinal grey matter changes in newly diagnosed Parkinson\u2019s disease: ICICLE-PD study","volume":"138","author":"Mak","year":"2015","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180823051321_awy211-B95","first-page":"576","article-title":"Cognitive deficits in mild Parkinson\u2019s disease are associated with distinct areas of grey matter atrophy","author":"Mak","year":"2013","journal-title":"J Neurol Neurosurg. Psychiatry"},{"key":"key\n\t\t\t\t20180823051321_awy211-B96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.92641","article-title":"Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington\u2019s disease","volume":"2","author":"McColgan","year":"2017","journal-title":"JCI Insight"},{"key":"key\n\t\t\t\t20180823051321_awy211-B97","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/jcbfm.2015.112","article-title":"Abnormal metabolic pattern associated with cognitive impairment in Parkinson\u2019s disease: a validation study","volume":"35","author":"Meles","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"key\n\t\t\t\t20180823051321_awy211-B98","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1212\/WNL.0b013e3182929f62","article-title":"White matter microstructure deteriorates across cognitive stages in Parkinson disease","volume":"80","author":"Melzer","year":"2013","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180823051321_awy211-B99","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/jnnp-2011-300828","article-title":"Grey matter atrophy in cognitively impaired Parkinson\u2019s disease","volume":"83","author":"Melzer","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20180823051321_awy211-B100","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1093\/brain\/awp223","article-title":"Impaired visual processing preceding image recognition in Parkinson\u2019s disease patients with visual hallucinations","volume":"132","author":"Meppelink","year":"2009","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180823051321_awy211-B101","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.clineuro.2004.12.005","article-title":"Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson\u2019s disease with and without dementia, and Alzheimer\u2019s disease","volume":"107","author":"Mito","year":"2005","journal-title":"Clin Neurol Neurosurg"},{"key":"key\n\t\t\t\t20180823051321_awy211-B102","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1523\/JNEUROSCI.4860-03.2004","article-title":"Neural bases of set-shifting deficits in Parkinson\u2019s disease","volume":"24","author":"Monchi","year":"2004","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20180823051321_awy211-B103","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.neuroimage.2006.06.058","article-title":"Striatal dopamine release during performance of executive functions: a [11C] raclopride PET study","volume":"33","author":"Monchi","year":"2006","journal-title":"Neuroimage"},{"key":"key\n\t\t\t\t20180823051321_awy211-B104","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/brain\/awl326","article-title":"Cortical activity in Parkinson\u2019s disease during executive processing depends on striatal involvement","volume":"130","author":"Monchi","year":"2007","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180823051321_awy211-B105","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pscychresns.2012.06.001","article-title":"Predicting dementia development in Parkinson\u2019s disease using Bayesian network classifiers","volume":"213","author":"Morales","year":"2013","journal-title":"Psychiatry Res"},{"key":"key\n\t\t\t\t20180823051321_awy211-B106","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.immuni.2018.01.011","article-title":"High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease","volume":"48","author":"Mrdjen","year":"2018","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20180823051321_awy211-B107","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3174\/ajnr.A4260","article-title":"Usefulness of quantitative susceptibility mapping for the diagnosis of Parkinson disease","volume":"36","author":"Murakami","year":"2015","journal-title":"Am J Neuroradiol"},{"key":"key\n\t\t\t\t20180823051321_awy211-B108","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neurobiolaging.2013.06.025","article-title":"Effect of mild cognitive impairment on the patterns of neural activity in early parkinson\u2019s disease","volume":"35","author":"Nagano-Saito","year":"2014","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t20180823051321_awy211-B109","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neuropsychologia.2017.09.034","article-title":"Neural evidence for defective top-down control of visual processing in Parkinson\u2019s and Alzheimer\u2019s disease","volume":"106","author":"Nemcova","year":"2017","journal-title":"Neuropsychologia"},{"key":"key\n\t\t\t\t20180823051321_awy211-B110","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1212\/WNL.0000000000004201","article-title":"Loss of phosphodiesterase 4 in Parkinson disease relevance to cognitive deficits","volume":"89","author":"Niccolini","year":"2017","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180823051321_awy211-B111","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/mds.22381","article-title":"Amnestic mild cognitive impairment in Parkinson\u2019s disease: a brain perfusion SPECT study","volume":"24","author":"Nobili","year":"2009","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20180823051321_awy211-B112","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/mds.22899","article-title":"Cognitive-nigrostriatal relationships in de novo, drug-naive Parkinson\u2019s disease patients: a [I-123]FP-CIT SPECT study","volume":"25","author":"Nobili","year":"2010","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20180823051321_awy211-B113","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jns.2014.09.049","article-title":"Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson\u2019s disease with mild cognitive impairment","volume":"347","author":"Noh","year":"2014","journal-title":"J Neurol Sci"},{"key":"key\n\t\t\t\t20180823051321_awy211-B114","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/brain\/awu201","article-title":"Genetic impact on cognition and brain function in newly diagnosed Parkinson\u2019s disease: ICICLE-PD study","volume":"137","author":"Nombela","year":"2014","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180823051321_awy211-B115","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1093\/brain\/awv136","article-title":"Longitudinal changes in free-water within the substantia nigra of Parkinson\u2019s disease","volume":"138","author":"Ofori","year":"2015","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180823051321_awy211-B116","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/mds.20463","article-title":"Three-dimensional stereotactic surface projection SPECT analysis in Parkinson\u2019s disease with and without dementia","volume":"20","author":"Osaki","year":"2005","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20180823051321_awy211-B117","doi-asserted-by":"crossref","first-page":"e54980","DOI":"10.1371\/journal.pone.0054980","article-title":"Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson\u2019s disease","volume":"8","author":"Pagonabarraga","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180823051321_awy211-B118","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000345537","article-title":"Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson\u2019s disease","volume":"34","author":"Pagonabarraga","year":"2012","journal-title":"Dement Geriatr Cogn Disord"},{"key":"key\n\t\t\t\t20180823051321_awy211-B119","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/jamaneurol.2013.2110","article-title":"Prognosis of mild cognitive impairment in early parkinson disease","volume":"70","author":"Pedersen","year":"2013","journal-title":"JAMA Neurol"},{"key":"key\n\t\t\t\t20180823051321_awy211-B120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/ane.12365","article-title":"Cognitive performances and DAT imaging in early Parkinson\u2019s disease with mild cognitive impairment: a preliminary study","volume":"131","author":"Pellecchia","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"key\n\t\t\t\t20180823051321_awy211-B202","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1002\/hbm.22822","article-title":"Aberrant cerebral network topology and mild cognitive impairment in early Parkinson's disease","volume":"36","author":"Pereira","year":"2015","journal-title":"Hum Brain Mapp"},{"key":"key\n\t\t\t\t20180823051321_awy211-B121","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1212\/WNL.0000000000000483","article-title":"Initial cognitive decline is associated with cortical thinning in early Parkinson disease","volume":"82","author":"Pereira","year":"2014","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180823051321_awy211-B122","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/jnnp.48.5.413","article-title":"Cholinergic correlates of cognitive impairment in Parkinson\u2019s disease: comparisons with Alzheimer\u2019s disease","volume":"48","author":"Perry","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20180823051321_awy211-B123","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/mds.26191","article-title":"Amyloid deposition in Parkinson\u2019s disease and cognitive impairment: a systematic review","volume":"30","author":"Petrou","year":"2015","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20180823051321_awy211-B124","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/brain\/awv361","article-title":"Free-water imaging in Parkinson\u2019s disease and atypical parkinsonism","volume":"139","author":"Planetta","year":"2016","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180823051321_awy211-B125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.neurobiolaging.2016.09.001","article-title":"Regional expression of the MAPT gene is associated with loss of hubs in brain networks and cognitive impairment in Parkinson disease and progressive supranuclear palsy","volume":"48","author":"Rittman","year":"2016","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t20180823051321_awy211-B126","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.acra.2013.09.018","article-title":"Imaging brain iron and diffusion patterns. A follow-up study of Parkinson\u2019s disease in the initial stages","volume":"21","author":"Rossi","year":"2014","journal-title":"Acad Radiol"},{"key":"key\n\t\t\t\t20180823051321_awy211-B127","first-page":"S6","article-title":"Slowing the progression of Alzheimer disease: monitoring progression","volume":"11","author":"Rossor","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"key\n\t\t\t\t20180823051321_awy211-B128","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1093\/brain\/awn112","article-title":"Parkinson\u2019s disease and dopaminergic therapy\u2014differential effects on movement, reward and cognition","volume":"131","author":"Rowe","year":"2008","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180823051321_awy211-B129","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.neuroimage.2009.10.003","article-title":"Complex network measures of brain connectivity: uses and interpretations","volume":"52","author":"Rubinov","year":"2010","journal-title":"Neuroimage"},{"key":"key\n\t\t\t\t20180823051321_awy211-B130","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/jnnp.55.10.960","article-title":"SPECT findings in Parkinson\u2019s disease associated with dementia","volume":"55","author":"Sawada","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20180823051321_awy211-B131","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/brain\/awn054","article-title":"Cognitive deficits and striato-frontal dopamine release in Parkinson\u2019s disease","volume":"131","author":"Sawamoto","year":"2008","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180823051321_awy211-B132","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/1533317517698794","article-title":"Accelerated age-dependent hippocampal volume loss in parkinson disease with mild cognitive impairment","volume":"32","author":"Schneider","year":"2017","journal-title":"Am J Alzheimers Dis Other Dement"},{"key":"key\n\t\t\t\t20180823051321_awy211-B133","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(16)30328-3","article-title":"Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson\u2019s disease: a cohort study","volume":"16","author":"Schrag","year":"2016","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20180823051321_awy211-B134","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","article-title":"The synaptic pathology of \u03b1-synuclein aggregation in dementia with Lewy bodies, Parkinson\u2019s disease and Parkinson\u2019s disease dementia","volume":"120","author":"Schulz-Schaeffer","year":"2010","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180823051321_awy211-B135","doi-asserted-by":"crossref","first-page":"e93814","DOI":"10.1371\/journal.pone.0093814","article-title":"The \u2018swallow tail\u2019 appearance of the healthy nigrosome\u2014a new accurate test of Parkinson\u2019s disease: a case-control and retrospective cross-sectional MRI study at 3T","volume":"9","author":"Schwarz","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180823051321_awy211-B136","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/mds.25982","article-title":"Cortical thinning associated with mild cognitive impairment in Parkinson\u2019s disease","volume":"29","author":"Segura","year":"2014","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20180823051321_awy211-B137","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1212\/WNL.0b013e3181ab2b58","article-title":"Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET","volume":"73","author":"Shimada","year":"2009","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180823051321_awy211-B138","doi-asserted-by":"crossref","first-page":"e110547","DOI":"10.1371\/journal.pone.0110547","article-title":"Neural substrates of cognitive subtypes in Parkinson\u2019s disease: a 3-year longitudinal study","volume":"9","author":"Shoji","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180823051321_awy211-B139","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/mds.26051","article-title":"Cognitive executive impairment and dopaminergic deficits in de novo Parkinson\u2019s disease","volume":"29","author":"Siepel","year":"2014","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20180823051321_awy211-B140","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/mds.23477","article-title":"The pattern of cortical atrophy in patients with Parkinson\u2019s disease according to cognitive status","volume":"26","author":"Song","year":"2011","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20180823051321_awy211-B141","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180823051321_awy211-B142","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00401-009-0556-6","article-title":"Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer\u2019s disease","volume":"118","author":"Streit","year":"2009","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180823051321_awy211-B143","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13195-014-0077-y","article-title":"Evaluating the relationship between amyloid-\u03b2 and \u03b1-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson\u2019s disease","volume":"6","author":"Swirski","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"key\n\t\t\t\t20180823051321_awy211-B144","doi-asserted-by":"crossref","first-page":"e0152716","DOI":"10.1371\/journal.pone.0152716","article-title":"Cerebral metabolic differences associated with cognitive impairment in Parkinson\u2019s disease","volume":"11","author":"Tang","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180823051321_awy211-B145","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3233\/JPD-150583","article-title":"Hypometabolism in posterior and temporal areas of the brain is associated with cognitive decline in Parkinson\u2019s disease","volume":"5","author":"Tard","year":"2015","journal-title":"J Parkinsons Dis"},{"key":"key\n\t\t\t\t20180823051321_awy211-B146","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1212\/WNL.0b013e31827689d6","article-title":"Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease","volume":"79","author":"Tessitore","year":"2012","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180823051321_awy211-B147","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fneur.2013.00037","article-title":"White-matter changes correlate with cognitive functioning in Parkinson\u2019s disease","volume":"4","author":"Theilmann","year":"2013","journal-title":"Front Neurol"},{"key":"key\n\t\t\t\t20180823051321_awy211-B148","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00401-015-1526-9","article-title":"Pathological \u03b1-synuclein distribution in subjects with coincident Alzheimer\u2019s and Lewy body pathology","volume":"131","author":"Toledo","year":"2016","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180823051321_awy211-B149","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1002\/hbm.22873","article-title":"Impaired planning in Parkinson\u2019s disease is reflected by reduced brain activation and connectivity","volume":"36","author":"Trujillo","year":"2015","journal-title":"Hum Brain Mapp"},{"key":"key\n\t\t\t\t20180823051321_awy211-B150","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1098\/rstb.2015.0362","article-title":"Gene transcription profiles associated with inter-modular hubs and connection distance in human functional magnetic resonance imaging networks","volume":"371","author":"V\u00e9rtes","year":"2016","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"key\n\t\t\t\t20180823051321_awy211-B151","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/brain\/awr277","article-title":"Alzheimer\u2019s disease pattern of brain atrophy predicts cognitive decline in Parkinson\u2019s disease","volume":"135","author":"Weintraub","year":"2012","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180823051321_awy211-B152","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1093\/brain\/awp245","article-title":"The distinct cognitive syndromes of Parkinson\u2019s disease: 5 year follow-up of the CamPaIGN cohort","volume":"132","author":"Williams-Gray","year":"2009","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180823051321_awy211-B153","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/brain\/awm313","article-title":"Attentional control in Parkinson\u2019s disease is dependent on COMT val158met genotype","volume":"131","author":"Williams-Gray","year":"2008","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180823051321_awy211-B154","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1523\/JNEUROSCI.0774-07.2007","article-title":"Catechol O-methyltransferase val158met genotype influences frontoparietal activity during planning in patients with Parkinson\u2019s disease","volume":"27","author":"Williams-Gray","year":"2007","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20180823051321_awy211-B155","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/jnnp-2013-305277","article-title":"The CamPaIGN study of Parkinson\u2019s disease: 10-year outlook in an incident population-based cohort","volume":"84","author":"Williams-Gray","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20180823051321_awy211-B156","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.neurobiolaging.2014.12.006","article-title":"Association between MAPT haplotype and memory function in patients with Parkinson\u2019s disease and healthy aging individuals","volume":"36","author":"Winder-Rhodes","year":"2015","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t20180823051321_awy211-B157","doi-asserted-by":"crossref","first-page":"e02444","DOI":"10.7554\/eLife.02444","article-title":"Complete morphologies of basal forebrain cholinergic neurons in the mouse","volume":"2014","author":"Wu","year":"2014","journal-title":"Elife"},{"key":"key\n\t\t\t\t20180823051321_awy211-B158","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1002\/hbm.22577","article-title":"The default mode network is disrupted in parkinson\u2019s disease with visual hallucinations","volume":"35","author":"Yao","year":"2014","journal-title":"Hum Brain Mapp"},{"key":"key\n\t\t\t\t20180823051321_awy211-B159","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1212\/WNL.0000000000000066","article-title":"Characterising mild cognitive impairment in incident Parkinson\u2019s disease: the ICICLE-PD study","volume":"82","author":"Yarnall","year":"2014","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180823051321_awy211-B160","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.neuroimage.2012.03.072","article-title":"NODDI: iractical in vivo neurite orientation dispersion and density imaging of the human brain","volume":"61","author":"Zhang","year":"2012","journal-title":"Neuroimage"},{"key":"key\n\t\t\t\t20180823051321_awy211-B161","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/hbm.22256","article-title":"DTI correlates of distinct cognitive impairments in Parkinson\u2019s disease","volume":"35","author":"Zheng","year":"2014","journal-title":"Hum Brain Mapp"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awy211\/25530965\/awy211.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T07:26:04Z","timestamp":1720423564000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/advance-article\/doi\/10.1093\/brain\/awy211\/5078251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,22]]},"references-count":164,"URL":"https:\/\/doi.org\/10.1093\/brain\/awy211","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,22]]}}}